A study by Zhao et al. demonstrated that the KRAS-ERK axis is responsible for positively regulating CD44 expression in response to radiation in GBM, as well as negatively regulating the expression of microRNAs miR-185 and miR-202. The gene discussed is CD44; the disease is glioblastoma.